TY - JOUR TI - What the interventionalist should know about renal denervation in hypertensive patients: A position paper by the ESH WG on the interventional treatment of hypertension AU - Tsioufis, C. AU - Mahfoud, F. AU - Mancia, G. AU - Redon, J. AU - Damascelli, B. AU - Zeller, T. AU - Schmieder, R.E. JO - EuroIntervention PY - 2014 VL - 9 TODO - 9 SP - 1027-1035 PB - EuroPCR SN - 1774-024X, 1969-6213 TODO - 10.4244/EIJV9I9A175 TODO - acetylsalicylic acid; aldosterone antagonist; antihypertensive agent; antithrombocytic agent; clopidogrel; diuretic agent; fentanyl; gadolinium; glyceryl trinitrate; heparin; hydroxymethylglutaryl coenzyme A reductase inhibitor; metformin; midazolam; morphine; nitrate; nonsteroid antiinflammatory agent, ablation catheter; anatomical variation; artery diameter; article; balloon catheter; catheter ablation; chronic kidney disease; computed tomographic angiography; drug megadose; human; hypertension; kidney angiography; kidney artery stenosis; kidney denervation; magnetic resonance angiography; nerve regeneration; radiofrequency ablation device; renal artery; sympathetic nerve; ultrasound therapy; visceral pain, Blood Pressure; Denervation; Humans; Hypertension; Kidney; Kidney Diseases; Renal Artery TODO - Percutaneous catheter-based transluminal renal denervation (RDN) has emerged as a new approach to achieve sustained blood pressure reduction in patients with drug-resistant hypertension. Experts from ESH and ESC in their recently released position papers and consensus document have summarised the current evidence, unmet needs and practical recommendations for the application of this therapeutic strategy in clinical practice. Experts of the ESH Working Group for the interventional treatment of hypertension prepared this position paper in order to provide interventionalists with guidance through the procedure of RDN. Given that there is no established intraprocedural control of ablation success, interventionalists have to be familiar with the aspects related to the anatomy and imaging of the renal arteries, the distribution of renal sympathetic fibres, the special equipment necessary for RDN and the procedural details in order to maximise the success and minimise potential complications. © Europa Digital & Publishing 2014. All rights reserved. ER -